Latest Strategic Investment News

Page 2 of 96
PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.
Ada Torres
Ada Torres
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
BSP Financial Group has reported a robust 12.9% increase in net profit for 2025, underpinned by strong revenue growth and strategic restructuring, including converting its Fiji branch into a wholly owned subsidiary.
Claire Turing
Claire Turing
20 Feb 2026
Latitude Group Holdings Limited reported a robust 59% increase in Cash NPAT for FY25, driven by strong volume growth and margin expansion, while declaring a fully franked 9.00 cents per share dividend.
Claire Turing
Claire Turing
20 Feb 2026
Peter Warren Automotive Holdings reported a 3.2% revenue increase to $1.268 billion and more than doubled its profit after tax to $7.435 million in the first half of FY26, declaring a fully franked interim dividend of 3.0 cents per share.
Victor Sage
Victor Sage
20 Feb 2026
MaxiPARTS Limited reported a modest 1.8% revenue increase to $139.3 million for the half-year ended December 2025, while net profit after tax dipped slightly by 2%. The company raised its interim dividend to 4.15 cents per share, reflecting confidence in its growth initiatives and cash flow outlook.
Victor Sage
Victor Sage
19 Feb 2026
360 Capital REIT reported a 63.2% rise in statutory profit to $3.1 million for H1 2026, maintaining distributions and expanding its portfolio with a $10 million Sydney apartment block investment.
Eva Park
Eva Park
19 Feb 2026
Universal Store Holdings has reported a robust first half of FY26, with sales and profits climbing significantly across its key brands, supported by margin gains and strategic investments.
Logan Eniac
Logan Eniac
19 Feb 2026
PlaySide Studios has secured a global publishing agreement with Swedish developer MVRX Games for the upcoming co-op platformer 'Dew', aiming for a 2028 PC and console release. This deal marks a strategic expansion of PlaySide’s publishing portfolio, backed by a multi-million AUD investment.
Sophie Babbage
Sophie Babbage
19 Feb 2026
Australian Vintage reports steady first-half sales and outlines a robust strategy focused on innovation, portfolio diversification, and global expansion to meet full-year growth targets.
Victor Sage
Victor Sage
19 Feb 2026
Emeco Holdings Limited has reported a solid 15% increase in net profit for the half year ending December 2025, alongside a 9% rise in revenue, while opting to maintain a no-dividend payout policy.
Victor Sage
Victor Sage
19 Feb 2026